Statins: Powerful drugs for lowering cholesterol: Advice for patients

Circulation

Volumn 105, Issue 13, 2002, Pages 1514-1516

  Gotto Jr , Antonio M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CHOLESTEROL;

CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIET; EXERCISE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; ARTICLE; BIOLOGICAL MODEL; BLOOD; HEART DISEASE;

CHOLESTEROL; DIET; EXERCISE; HEART DISEASES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MODELS, BIOLOGICAL; RISK FACTORS;

EID: 0037007254     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000014245.25136.D2     Document Type: Short Survey

References (6)

1. Expert Panel on the Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
3. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
4. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
5. Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): Additional perspectives on tolerability of long-term treatment with lovastatin
6. MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: Early safety efficacy experience